Clinical features | Reported phenotype | Patient-1 | Patient-2 |
---|---|---|---|
Pregnancy and delivery complications: | 35 to 43 weeks, birth weight: 3534g, maternal hypertension, mild bleeding, normal delivery for majority of patients. | Normal pregnancy, birth weight: 3300g, delivery by caesarean section, maternal hypertension, pre-eclampsia and breech presentation. | Normal pregnancy, birth weight: 3000g, delivery by caesarean section, maternal hypertension, pre-eclampsia and breech presentation. |
First signs and symptoms: | Normal development until one year, later on developmental and speech delay with behavioral problems. | Normal development until one year, later on motor and speech delay. | Normal development until 1.5 years, later on motor and speech delay. |
Facial dysmorphisms. | Negative. | Negative. | |
Hepatomegaly. | Negative. | Negative. | |
Recurrent diarrhea. | Negative. | Negative. | |
Recurrent ear, nose and/or throat (ENT) infections. | Negative. | Negative. | |
Age of diagnosis: | Median age of 4 years (range 2 to 47 years). | 12 years. | 10 years. |
Behavioral problems: | Before 10 years of age: restlessness, temper tantrum, crying fits, hyperactivity, destructive and compulsive behavior and complete loss of initiative in the majority of patients. | At age three to four years: restlessness. | At age three to four years: restlessness. |
At age 10 to 11 years: complete loss of initiative with autistic-like behavior. | At age 10 to 11 years: complete loss of initiative with autistic-like behavior. | ||
Sleeping problems: | Onset at a median age of 4 years (range 0 to 35 years) with difficulties of falling asleep and frequent nocturnal wakening. | No sleep disturbance. | No sleep disturbance. |
Hearing problems: | Present in about 40% of patients. | Moderate to severe sensory bilateral hearing loss; abnormal auditory potentials (BAER). | Moderate to severe sensory bilateral hearing loss; abnormal auditory potentials (BAER). |
Visual problems: | Formal visual testing not possible. | Formal visual testing not possible. | Formal visual testing not possible. |
Fundoscopy: | Retinitis pigmentosa one-third of patients older than 21 years. | Normal. | Normal. |
Epilepsy: | About 66% developed epilepsy at a median age of 11 years (range 1 to 43 years), but well controlled by medication. | Onset of epileptic seizure at the age of 11 years but well controlled by valproic acid. | None. |
Age at death: | Median 18 years (range 6 to 59). | Current age 13 years. | Current age 11 years. |
Joint contractures: | Present. | Present. | Present. |
Scoliosis: | Present. | Present. | Present. |
Kyphosis: | Present. | Present. | Present. |
Pes cavus: | Not described. | Present. | Present. |
Skin discoloration: | Not described. | Present. | Present. |
Dysmorphic features: | Present. | Obvious at 10 to 11 years of age. | Obvious at 10 to 11 years of age. |
Magnetic resonance imaging (MRI) findings: | Not reported. | Diffuse hypomyelination, thin corpus callosum and progressive cerebral atrophy. | Diffuse hypomyelination and thin corpus callosum. |